DBD

The average brokerage recommendation (ABR) for Diebold Nixdorf, Incorporated (DBD) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Zacks.com users have recently been watching Diebold Nixdorf, Incorporated (DBD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Banking and retail technology provider Diebold Nixdorf (NYSE:DBD) reported Q3 2026 results topping the market’s revenue expectations, with sales up 4.8% year on year to $990.9 million. On the other hand, the company’s full-year revenue guidance of $3.88 billion at the midpoint came in 0.7% below analysts’ estimates. Its non-GAAP profit of $1.34 per share was 2.6% above analysts’ consensus estimate

Diebold Nixdorf’s third quarter was marked by steady revenue growth and ongoing challenges in profitability, prompting a significant negative reaction from the market. Management pointed to robust performance in its retail technology segment, especially in North America and Europe, and highlighted continued adoption of its SmartVision AI solutions. However, CEO Octavio Marquez acknowledged persist

2026-10-31. The following slide deck was published by Diebold Nixdorf, Incorporated in conjunction with their 2026 Q3 earnings call.

Diebold Nixdorf reported third quarter 2026 revenue of US$994.3 million and net income of US$6.6 million, then cut full year revenue, adjusted EBITDA and EPS guidance, while announcing a new US$250 million share repurchase plan. Guidance was reduced despite retail strength and a planned ATM outsourcing collaboration with Euronet, as elevated component and raw material costs and an unfavorable prod